Dendritic cell marker Clec4a4 deficiency limits atherosclerosis progression

Dendritic cell marker Clec4a4 deficiency limits atherosclerosis progression

Background and aims: Atherogenesis results from altered lipid metabolism and impaired immune response. Emerging evidence has suggested that dendritic cells (DCs) participate to atherosclerosis-related immune response, but their impact is scarcely characterized. Clec4a4 or DCIR2 (Dendritic cell immun...

Full description

Bibliographic Details
Main Authors: Rossella Bellini, Annalisa Moregola, Jasmine Nour, Yoann Rombouts, Olivier Neyrolles, Patrizia Uboldi, Fabrizia Bonacina, Giuseppe Danilo Norata
Format: Article
Language:English
Published: Elsevier 2023-03-01
Series:Atherosclerosis Plus
Subjects:
Clec4a4
Atherosclerosis
C-type lectin receptors
Dendritic cells
Immune response
Online Access:http://www.sciencedirect.com/science/article/pii/S2667089522000591

Internet

http://www.sciencedirect.com/science/article/pii/S2667089522000591

Similar Items